Legend Biotech (LEGN) Net Cash Flow (2019 - 2025)

Legend Biotech has reported Net Cash Flow for 7 years, with the latest figure at $625.7 million in Q4 2025.

• For the quarter ending Q4 2025, Net Cash Flow rose 467.41% year-over-year to $625.7 million; the trailing twelve-month figure through Dec 2025 stood at $609.2 million (up 161.6% YoY), and the FY2025 full-year result was $609.1 million, up 161.59% from the prior year.
• Net Cash Flow for Q4 2025 stood at $625.7 million, up from $9.5 million in the prior quarter.
• The five-year high for Net Cash Flow was $625.7 million in Q4 2025, with the low at -$696.3 million in Q2 2024.
• Historically, Net Cash Flow has averaged -$4.0 million across 5 years, with a median of -$56.8 million in 2021.
• Annual changes were most pronounced in 2022 — Net Cash Flow slumped 611.55% — and 2023, when it surged 19899.89%.
• Legend Biotech's Net Cash Flow stood at -$69.9 million in 2021, then tumbled by 84.4% to -$128.9 million in 2022, then surged by 342.72% to $312.8 million in 2023, then sank by 154.45% to -$170.3 million in 2024, then jumped by 467.41% to $625.7 million in 2025.
• The last three Net Cash Flow figures came in at $625.7 million (Q4 2025), $9.5 million (Q3 2025), and -$179.6 million (Q2 2025), per Business Quant data.